CRISPR THERAPEUTICS AG (CRSP) /
The revenue of CRISPR THERAPEUTICS AG over the past 10 years
Chart CRISPR THERAPEUTICS AG: revenue, fiscal 2016–2025 Open the chart →CRISPR THERAPEUTICS AG reported revenue of $3.51M in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $5.16M — down 32% over 9 years. Year over year, revenue rose 4 times and fell 5 times. In these years the highest was $914.96M in fiscal 2021; the lowest $719K in fiscal 2020. The largest one-year move was in fiscal 2021: up 127155%, from $719K to $914.96M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $3.51M |
| 2024ended Dec 31, 2024 | $37.31M |
| 2023ended Dec 31, 2023 | $371.21M |
| 2022ended Dec 31, 2022 | $1.2M |
| 2021ended Dec 31, 2021 | $914.96M |
| 2020ended Dec 31, 2020 | $719K |
| 2019ended Dec 31, 2019 | $289.59M |
| 2018ended Dec 31, 2018 | $3.12M |
| 2017ended Dec 31, 2017 | $41M |
| 2016ended Dec 31, 2016 | $5.16M |
Fiscal years as CRISPR THERAPEUTICS AG reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on CRISPR THERAPEUTICS AG
- The profitability of CRISPR THERAPEUTICS AG
- The cash flow of CRISPR THERAPEUTICS AG
- The debt of CRISPR THERAPEUTICS AG
- All of CRISPR THERAPEUTICS AG's financials, charted
Companies of a similar size
- CUZCOUSINS PROPERTIES INC
- CIGIColliers International Group Inc.
- RYNRAYONIER INC.
- MATMATTEL INC /DE/
- NWENORTHWESTERN ENERGY GROUP, INC.
Not investment advice. This page shows what CRISPR THERAPEUTICS AG filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.